Sensenig Bethany bought SUPN

February 19, 2026 · Form 4 insider transaction

Sensenig Bethany bought 4,475 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.